Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menopause01:28

Menopause

3.5K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.5K
Bone Disorders01:29

Bone Disorders

5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

3.8K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Acute and longitudinal magnetic resonance imaging abnormalities in antibody-mediated encephalitis.

Brain communications·2026
Same author

Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission.

Journal of the neurological sciences·2026
Same author

Population-based Brain Templates for Ultra-Low-Field MRI.

Scientific data·2026
Same author

Incidence of idiopathic intracranial hypertension (IIH) in adults and children: a 14-year population-based study.

Journal of neurology·2026
Same author

Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

Neurology·2026

Related Experiment Video

Updated: Jan 6, 2026

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.2K

Menopause Impact on Multiple Sclerosis Disability Progression.

Francesca Bridge1,2, Paul G Sanfilippo1, Chao Zhu1

  • 1Department of Neuroscience, School of Translational Medicine, Monash University.

JAMA Neurology
|September 29, 2025
PubMed
Summary
This summary is machine-generated.

Menopause does not significantly increase disability progression in women with multiple sclerosis (MS). This study found no link between menopause and worsening MS symptoms or developing secondary progressive MS.

More Related Videos

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

16.0K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.6K

Related Experiment Videos

Last Updated: Jan 6, 2026

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.2K
A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

16.0K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.6K

Area of Science:

  • Neurology
  • Reproductive Health
  • Epidemiology

Background:

  • Most women with multiple sclerosis (MS) experience menopause during their disease course.
  • The influence of menopause on MS progression remains poorly understood.

Purpose of the Study:

  • To investigate if menopause alters the risk of disability progression in women with relapse-onset MS.
  • To analyze the association between menopause and key MS disease milestones.

Main Methods:

  • Retrospective cohort study using prospective data from the MSBase Registry.
  • Included 987 women with relapse-onset MS, analyzing menopausal status and disability progression (Expanded Disability Status Scale - EDSS).
  • Used Cox proportional hazards models, adjusting for age at MS onset, disease duration, baseline EDSS, relapses, and disease-modifying therapy.

Main Results:

  • Menopause was not associated with an increased risk of 6-month confirmed disability progression (CDP) or secondary progressive MS (SPMS).
  • Hazard ratios for CDP and SPMS were 0.95 (95% CI, 0.70-1.29) and 1.00 (95% CI, 0.60-1.67), respectively.
  • Menopause did not represent a significant inflection point for EDSS worsening in secondary analysis.

Conclusions:

  • Findings do not support menopause as a primary driver of disability progression in older women with MS.
  • While reproductive aging may contribute, it is not the leading factor for increased disability.
  • Further research may explore the interplay of somatic and reproductive aging in MS.